ArticleAmerican journal of ophthalmology case reports2026
Conjunctival stromal tumor in an 18-month-old girl: A case report.
Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report an unusual case of conjunctival stromal tumor (COST) located in the punctum of the eyelid in an 18-month-girl. Observation: The patient is an 18-month female, with no significant medical history or ocular trauma, who presented with a slowly growing mass on the punctum of her right-upper eyelid. Ophthalmic exam showed that the lesion was not attached to the globe of the eye. The lesion was completely surgically excised. Histopathological analysis showed a well-circumscribed polypoid nodule comprised of bland spindled cells with pseudonuclear inclusions and giant cells with floret-like nuclear configurations. The immunohistochemical staining pattern was consistent with COST. Conclusion: COST is an emerging entity first described in 2012 and rarely reported in children. Herein, we report the third diagnosis of COST in a child, the youngest age reported to date. As such, it should be considered in the differential diagnosis of a conjunctival lesion regardless of age. In the differential diagnosis, it is important to distinguish COST from conjunctival myxoma given the syndromic associations of the latter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.